Creamy Dream: The Magic of Mush Overnight Oats

Which is the tablet to reduce obesity?

 There are several types of tablets or medications that are approved by regulatory authorities such as the FDA for the treatment of obesity. These medications are usually prescribed to people with a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher if they have other risk factors such as high blood pressure, diabetes, or high cholesterol.


The most common types of weight loss medications are:


Orlistat: Orlistat is a medication that works by reducing the absorption of dietary fat in the intestine. It is sold under the brand name Xenical and is available over the counter as Alli. Orlistat is approved for long-term use and has been shown to be effective in promoting weight loss in obese individuals.


Phentermine: Phentermine is a stimulant medication that suppresses appetite and can help with weight loss. It is usually prescribed for short-term use, typically for a few weeks, due to the risk of dependence and other side effects.


Lorcaserin: Lorcaserin is a serotonin receptor agonist that works by reducing appetite and increasing feelings of fullness. It is sold under the brand name Belviq and is approved for long-term use. However, it has been withdrawn from the market due to safety concerns.


Naltrexone/bupropion: This combination medication works by reducing cravings and appetite while increasing energy expenditure. It is sold under the brand name Contrave and is approved for long-term use.


Liraglutide: Liraglutide is a medication that mimics the action of a hormone called GLP-1, which regulates appetite and metabolism. It is sold under the brand name Saxenda and is approved for long-term use.


It is important to note that weight loss medications should be used in conjunction with lifestyle changes such as diet and exercise, and under the guidance of a healthcare professional. They are not a magic solution to obesity and should only be used when other weight loss methods have failed or are not feasible

Comments